{
    "id": 4530,
    "fullName": "FGFR4 N535K",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR4 N535K lies within the protein kinase domain of the Fgfr4 protein (PMID: 19809159). N535K confers a gain of function to the Fgfr4 protein resulting in increased autophosphorylation, Stat3 signaling, and tumor proliferation (PMID: 19809159).",
            "references": [
                {
                    "id": 1834,
                    "pubMedId": 19809159,
                    "title": "Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19809159"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2264,
        "geneSymbol": "FGFR4",
        "terms": [
            "FGFR4",
            "CD334",
            "JTK2",
            "TKF"
        ]
    },
    "variant": "N535K",
    "createDate": "04/06/2015",
    "updateDate": "04/06/2015",
    "referenceTranscriptCoordinates": {
        "id": 164546,
        "transcript": "NM_213647",
        "gDna": "chr5:g.177095415C>G",
        "cDna": "c.1605C>G",
        "protein": "p.N535K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19463,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FGF401 induced tumor regression in a transgenic mouse model constitutively expressing FGFR4 N535K (PMID: 31409633).",
            "molecularProfile": {
                "id": 4322,
                "profileName": "FGFR4 N535K"
            },
            "therapy": {
                "id": 2031,
                "therapyName": "FGF401",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17101,
                    "pubMedId": 31409633,
                    "title": "FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31409633"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8392,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, rhabdomyosarcoma cells over expressing FGFR4 N535K demonstrated increased sensitivity to Iclusig (ponatinib), resulting in decreased tumor cell growth in culture and in cell line xenograft models (PMID: 24124571).",
            "molecularProfile": {
                "id": 4322,
                "profileName": "FGFR4 N535K"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3247,
                "name": "rhabdomyosarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 88,
                    "pubMedId": 24124571,
                    "title": "Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24124571"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4322,
            "profileName": "FGFR4 N535K",
            "profileTreatmentApproaches": [
                {
                    "id": 9744,
                    "name": "STAT3 Inhibitor",
                    "profileName": "FGFR4 N535K"
                },
                {
                    "id": 9746,
                    "name": "FGFR4 Inhibitor",
                    "profileName": "FGFR4 N535K"
                },
                {
                    "id": 9745,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR4 N535K"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 164546,
            "transcript": "NM_213647",
            "gDna": "chr5:g.177095415C>G",
            "cDna": "c.1605C>G",
            "protein": "p.N535K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164547,
            "transcript": "NM_002011",
            "gDna": "chr5:g.177095415C>G",
            "cDna": "c.1605C>G",
            "protein": "p.N535K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164548,
            "transcript": "XM_005265838",
            "gDna": "chr5:g.177095415C>G",
            "cDna": "c.1605C>G",
            "protein": "p.N535K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}